GovBidAlerts
← All opportunities

Serological Assays for the Detection and Characterization of Influenza Viruses

Key dates

Posted
Mar 26, 2025
Response deadline
May 22, 2025, 6:00 PM UTC
Archive date
—
Archive type
autocustom

Classification

Notice type
Solicitation
Base type
Solicitation
Set-aside
—
Set-aside code
—
PSC
Q301

NAICS

Issuing office

Department
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
CENTERS FOR DISEASE CONTROL AND PREVENTION
Office
CDC OFFICE OF ACQUISITION SERVICES
Office code
—
Organization type
OFFICE
Office address
ATLANTA, GA, 30333, USA

Place of performance

Street
—
Street 2
—
City
Atlanta
State
GA
Zip
—
Country
USA

Contacts

Description

Amendment 3 is being issued to amend the timeline for Phase I. The new ship date for the assays is March 31, 2025 with a delivery date of April 1, 2025. The due date for results is April 15, 2025. Additional information will be provided in the packages to answer any lingering questions. The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay. The steps in Phase I are as follows: Letter of Interest – offerors shall email POC information to Contracting Officer Proficiency panel will be sent by CDC to intersted offerors Vendor shall email results to CDC Contracting Officer CDC Contractng Officer will notify each offeror of their pass/fail status for Phase I and if they are then able to proceed to Phase II

Other notices in this solicitation

Similar open contracts

Metadata

Notice ID
dc73a610c43149ee82979ccc045cb9ff
Full path
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.CENTERS FOR DISEASE CONTROL AND PREVENTION.CDC OFFICE OF ACQUISITION SERVICES
Office code
—
Ingested
Jun 12, 2026
Updated
Jul 11, 2026